Virtual Physiological Human Institute for Integrative Biomedical Research

The VPH Institute promotes, supports, and pursues not-for-profit scientific research and development on integrative biomedicine and related topics. It sustains the synergistic coordination of all members’ efforts as well as those of the wider scientific, medical, industrial and institutional community toward the common goal of developing, testing and implementing integrative
biomedical science and technology-facilitated applications.
It is part of the specific objectives and activities which contribute to the accomplishment of the VPH Institute’s purpose:
- Establish a think-tank to advise and support governmental and non-governmental institutions on research & technology development programmes and initiatives on integrative biomedicine and related topics.
- Conduct or participate in studies to assess the status, the level of adoption, and the impact of integrative methods and technologies, and in any other studies, research or implementation projects to advance integrative biomedicine and related topics.
- Provide a single voice for all its members and the wider scientific, medical, industrial and institutional community that can contribute to sustain the development, assessment and deployment of the integrative biomedicine vision.
- Support standardisation processes to ensure interoperability of integrative technologies and the integration of data, information, knowledge, and understanding captured in digital format.
- Provide platforms for the exchange of ideas, challenges, solutions and experience between the heath-care industry, health-service providers and founders, and researchers.
- Foster and participate in the collaborative development, assessment, deployment, and maintenance of tools, services, and methods for biomedical integrative research and clinical practice.
- Manage, directly or through its member organisations, shared infrastructures to support the integrative approach in research and clinical practice.

Medical device directive
Data Protection
EMA regulation
Consultation for In Silico Medicine

1

0.25

No lobbyists with EP accreditations

None declared

Ms Liesbet Geris (Executive Director)

Mr Peter Hunter (President)

IV - Think tanks, research and academic institutions

Think tanks and research institutions